Clinical Trials Logo

Ischemic Stroke clinical trials

View clinical trials related to Ischemic Stroke.

Filter by:

NCT ID: NCT06401564 Recruiting - Ischemic Stroke Clinical Trials

Virtual Reality Based Rehabilitation After Ischemic Stroke

Start date: April 17, 2023
Phase: N/A
Study type: Interventional

Use the template below as a guide to write a brief study description in plain language. Tailor the text that appears in brackets and yellow to your research study. To finalize, delete the text in italics. The goal of this single-arm study is to explore the use of early virtual reality-based rehabilitation as an adjunct to conventional physical/occupational therapy in adult patients with acute ischemic stroke. The main question it aims to answer is: Feasibility and tolerability of using immersive Virtual Reality technology-based therapy for patients suffering from acute ischemic stroke in an inpatient hospital setting Participants will receive 1 or 2 virtual reality therapy sessions and complete surveys at the end of each session.

NCT ID: NCT06400407 Not yet recruiting - Clinical trials for Stroke, Acute Ischemic

Lesion Network MApping Navigated Continuous Theta-burst STimulation for Motor REcovery in Acute Ischemic Stroke

MASTRE
Start date: May 6, 2024
Phase: Phase 2
Study type: Interventional

This is a multicenter, sham-controlled, double-blind, randomized clinical trial to evaluate the efficacy and safety of lesion network mapping navigated cTBS in improving motor function in patients with acute ischemic stroke at 3-14 days after onset.

NCT ID: NCT06398366 Enrolling by invitation - Cryptogenic Stroke Clinical Trials

Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence

CASPR
Start date: September 14, 2022
Phase:
Study type: Observational

This is a multi-center retrospective analysis of consecutive adult patients with cryptogenic stroke patients following a comprehensive workup for the underlying stroke etiology. Patients will be eligible for inclusion if the index stroke event occurred between 1/1/2016 and 06/30/2022.

NCT ID: NCT06397638 Completed - Acute Stroke Clinical Trials

Rescue Carotid Stenting in Tandem Occlusions: 4-year Experience From a Comprehensive Stroke Centre

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The rescue carotid stenting has recently been an additional treatment followed by mechanical thrombectomy in tandem occlusions of the anterior circulation. Nevertheless, there were few data to date that support this beneficial treatment in Asia. The investigators hypothesized that this treatment related to improvement of clinical outcomes after procedure.

NCT ID: NCT06396858 Not yet recruiting - Ischemic Stroke Clinical Trials

Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke

ARCHIMEDES
Start date: July 2024
Phase: Phase 4
Study type: Interventional

The ARCHIMEDES study (Anti-inflammatory and anti-thRombotic therapy with colCHicine and low dose rIvaroxaban for Major adverse cardiovascular Events reDuction in ischEmic Stroke) will be a randomized, double-blind, 2x2 factorial clinical trial, which will include at least 3000 and up to a maximum of 4500 patients with ischemic stroke without indication of oral anticoagulation.

NCT ID: NCT06394180 Not yet recruiting - Clinical trials for Acute Ischemic Stroke

PeRforation EVents During ENdovascular Therapy for Acute Ischemic Stroke

PREVENT
Start date: June 2024
Phase:
Study type: Observational [Patient Registry]

A large, worldwide study called PREVENT is looking at a complication that can happen during a stroke treatment called thrombectomy. This complication is a perforation of a blood vessel. The investigators aim to: 1. Find what factors make this perforation more likely. 2. Understand why the perforation happens by looking closely at images taken during the procedure. 3. Create a simple way to classify these perforations to help doctors decide how to treat them right away. 4. Improve the emergent treatment of vessel perforation to stop the bleeding rapidly. 5. Provide data to guide decision whether thrombectomy should be continued or aborted after the event of vessel perforation. 6. Develop a safer way to perform thrombectomy. Investigators will compare the results collected for patients where perforation happened with those where perforation did not happen.

NCT ID: NCT06393218 Not yet recruiting - Bulbar Palsy Clinical Trials

The Impact of Diaphragm Training on Dysphagia in Bulbar Palsy After Ischemic Stroke

Start date: April 2024
Phase: N/A
Study type: Interventional

This was a prospective multicenter study. the patients after stroke with were randomly divided into the observation group and the control group. All patients were given comprehensive rehabilitation therapy. During the treatment, enteral nutrition support was provided for the two groups by Intermittent Oro-esophageal tube feeding. The observation group will be given Diaphragm Training Nutritional status, dysphagia, quality of life and depression before and after treatment were compared.

NCT ID: NCT06391502 Recruiting - Ischemic Stroke Clinical Trials

Vivifrail Program on the Degree of Debilitation in Hospitalized Patients After Venous Hemolysis in Acute Ischemic Stroke

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

Physical exercise is an effective strategy to maintain functional ability and improve debilitating symptoms in the elderly.In addition to functional enhancement, exercise is considered a cornerstone for enhancing cognitive function in debilitated older adults with cognitive impairment and dementia.The investigators evaluated the effect of the Vivifrail exercise intervention on the degree of debilitation in elderly hospitalized patients after venous hemolysis in acute ischemic stroke

NCT ID: NCT06388772 Completed - Clinical trials for Acute Ischemic Stroke

Study to Assess PK, Safety and Tolerability Early in Healthy Subjects

Start date: July 5, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of QHRD106 early in Chinese healthy subjects with single doses.

NCT ID: NCT06388148 Not yet recruiting - Clinical trials for Stroke, Acute Ischemic

Endovascular Treatment for eXtra-Large Ischemic Stroke

XL STROKE-2
Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The role of endovascular thrombectomy in patients with extra-large ischemic burden is still unclear. The XL STROKE-2 randomized trial is aiming to investigate the efficacy and safety of mechanical thrombectomy in acute extra-large ischemic stroke patients with large vessel occlusion.